Company Filing History:
Years Active: 2020-2023
Title: Usama Ahmed Fahmy: Innovator in Nano-Pharmaceuticals
Introduction
Usama Ahmed Fahmy is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of nano-pharmaceuticals, holding a total of 5 patents. His work focuses on innovative formulations that enhance medical treatments and improve patient outcomes.
Latest Patents
One of his latest patents is the "Icariin nano-pharmaceutical formulation." This formulation comprises zein nanoparticles that encapsulate icariin or its pharmaceutically acceptable salts. It also includes at least one solubilizer, specifically D-a-Tocopherol polyethylene glycol 1000 succinate (TPGS), along with one or more pharmaceutical penetration enhancers. This invention provides methods for enhancing libido through the administration of the described composition.
Another notable patent is "Thioctamer expedites wound healing." This invention features thioctamer, a nanoconjugate of glatiramer acetate and thioctic acid, presented in the form of nanospheres. The compositions comprising thioctamer are designed to accelerate wound healing when applied to wounds, demonstrating significant improvements compared to untreated control wounds.
Career Highlights
Usama Ahmed Fahmy is affiliated with King Abdulaziz University, where he conducts research and development in the field of pharmaceuticals. His innovative work has garnered attention and recognition within the scientific community.
Collaborations
He collaborates with esteemed colleagues, including Nabil Abdulhafiz Alhakamy and Osama A A Ahmed, contributing to advancements in their shared field of research.
Conclusion
Usama Ahmed Fahmy's contributions to nano-pharmaceuticals exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving health outcomes through advanced formulations.